Evidence map›Paper›PMID 41675310›Full record

ArticleTranslational gastroenterology and hepatology2026

The evolving role of ctDNA in colorectal cancer: guidance of adjuvant therapy or surveillance strategies?

Laura G Barrett, Alexandra Gangi, Andrew Hendifar, Arsen Osipov, Katelyn Atkins, Karen Zaghiyan, Yosef Nasseri, Zuri Murrell, Kevin Waters, Pareen Mehta and 3 more

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational gastroenterology and hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Laura G BarrettDepartment of Internal Medicine, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Alexandra GangiDivision of Surgical Oncology, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Andrew HendifarSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Arsen OsipovSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Katelyn AtkinsDepartment of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Karen ZaghiyanDivision of Surgical Oncology, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Yosef NasseriDivision of Surgical Oncology, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Zuri MurrellDivision of Surgical Oncology, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Kevin WatersDepartment of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Pareen MehtaDepartment of Radiology, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Jason A ZellDivision of Hematology/Oncology, University of California, Irvine, CA, USA.
Megan P HitchinsMoffitt Cancer Center, Tampa, FL, USA.
Jun GongSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adjuvant chemotherapy (ACT)circulating tumor DNA (ctDNA)Colon cancerminimal residual disease (MRD)

Identifiers

PMID41675310
PMCPMC12887280

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.